Less Ads, More Data, More Tools Register for FREE

Pin to quick picksPennant International Regulatory News (PEN)

Share Price Information for Pennant International (PEN)

Share Price is delayed by 15 minutes
Get Live Data
23.50    0.00 (0.00%)
Bid:
23.00
Ask:
24.00
Spread: 1.00 (4.348%)
Market Cap: £11.19m
PEN Live PriceLast checked at - London Stock Exchange

Intraday Pennant International Share Chart

Major Programme Update

3 Dec 2021 11:20

RNS Number : 5355U
Pennant International Group PLC
03 December 2021
 

FOR IMMEDIATE RELEASE

 

PENNANT INTERNATIONAL GROUP PLC

Major Programme Update

 

 

Pennant International Group plc (AIM:PEN)("Pennant", the "Group" or "Company"), a leading global provider of training technology and integrated product support solutions, provides the following pipeline update.

 

The Group was 'down-selected' for a major UK defence programme in August 2018 which was, at the time, anticipated to be contracted in that year.

 

The opportunity has since been subject to protracted negotiations between Pennant's customer and the Ministry of Defence and Pennant itself. This lengthy process has coincided with the Covid-19 pandemic, and with matters being paused for a time pending completion of the UK's 'Integrated Review of Security, Defence, Development and Foreign Policy'. At all points, the timing, scope and value of any contract award has been subject to contract.

 

With negotiations now believed to be drawing to a close, the Company has received written notification from the Ministry of Defence that Pennant's scope of supply will not be as substantial as originally contemplated. The Group's proposal in respect of certain items continues into final negotiation and the directors are increasingly confident that a contract (with a potential value now believed to be circa £9 million) will be secured in the first quarter of 2022.

 

Phil Walker, Group CEO, commented: "Given the length of time since the initial 'down-selection', our budgeting for the next three years had not assumed award of the full scope, and a contract worth in the region of £9 million, if awarded, will be a material win for us and substantially underpin our financial expectations for next year."

 

 

 

 

Certain information contained in this announcement would have constituted inside information (as defined by Article 7 of Regulation (EU) No 596/2014) ("MAR") prior to its release as part of this announcement and is disclosed in accordance with the Company's obligations under Article 17 of MAR.

 

 

Enquiries:

 

Pennant International Group plc

www.pennantplc.co.uk

Philip Walker, CEO

David Clements, Commercial & Risk Director

+44 (0) 1452 714 914

WH Ireland Limited (Nomad and Broker)

www.whirelandcb.com

Mike Coe

Sarah Mather

+44 (0) 20 7220 1666

Walbrook PR (Financial PR)

paul.vann@walbrookpr.com

Paul Vann

Tom Cooper

+44 (0)20 7933 8780

Mob: +44 (0)7768 807631

 

 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
UPDTJBBTMTBMBPB
Date   Source Headline
24th Sep 20247:00 amRNSDirector Dealing
23rd Sep 20247:00 amRNSInterim Results
19th Sep 20243:30 pmRNSNotice of Interim Results
3rd Sep 202411:00 amRNSIssue of Equity, Director Dealings & TVR
3rd Sep 20247:00 amRNSAppointment of NED & Interim CFO
14th Aug 20247:00 amRNSDirectorate Change
13th Aug 20245:20 pmRNSHolding(s) in Company
6th Aug 20241:36 pmRNSDirectors’ Dealings
2nd Aug 20247:00 amRNSDirectors’ Subscriptions
25th Jul 20247:00 amRNSTrading Update
17th Jul 202411:42 amRNSResult of AGM
17th Jul 20247:00 amRNSDirector Appointment & Notice of Trading Update
15th Jul 20247:00 amRNSChange of Adviser
25th Jun 202410:27 amRNSNotice of AGM & Posting of Accounts
21st Jun 20247:00 amRNS2023 Final Results
13th Jun 20245:41 pmRNSHolding(s) in Company
31st May 20244:32 pmRNSHolding(s) in Company
24th May 20247:00 amRNSResult of Placing and Subscription
23rd May 20244:30 pmRNSProposed Fundraising
14th May 20247:00 amRNSBusiness Update & Board Change
24th Apr 20242:44 pmRNSNotice of Results and Appointment of Board Adviser
7th Feb 20247:00 amRNSAppointment of Non-executive Director
7th Feb 20247:00 amRNSYear-End Trading Update
22nd Nov 202311:41 amRNSHolding(s) in Company
15th Nov 20235:20 pmRNSHolding(s) in Company
27th Sep 20237:00 amRNS2023 Interim Results
11th Sep 20237:00 amRNSNew Strategic Partnership
7th Sep 20237:00 amRNSPennant attending DSEI, London
19th Jul 20237:00 amRNSTrading Update & Notice of Interim Results
10th Jul 202310:39 amRNSIssue of Equity, Director Dealings & TVR
13th Jun 20237:00 amRNSBusiness Update: New Contract Wins
7th Jun 202310:40 amRNSResult of AGM
23rd May 202310:45 amRNSHolding in Company
22nd May 20233:15 pmRNSHolding in Company
16th May 202312:21 pmRNSHolding in Company
27th Apr 202311:31 amRNSNotice of AGM & Posting of 2022 Annual Accounts
26th Apr 20237:00 amRNS2022 Final Results
20th Apr 20237:00 amRNSNotice of 2022 Final Results
13th Apr 20237:00 amRNSAcquisition of UK Rail Services Business
16th Mar 20232:00 pmRNSHolding(s) in Company
14th Mar 20235:30 pmRNSHolding(s) in Company
23rd Feb 20231:13 pmRNSAppointment of Chair
8th Feb 202311:05 amRNSSecond Price Monitoring Extn
8th Feb 202311:00 amRNSPrice Monitoring Extension
8th Feb 20237:00 amRNSYear-end Trading Update
19th Jan 20239:31 amRNSHolding(s) in Company
12th Jan 202312:47 pmRNSAppointment of Director
9th Nov 20227:00 amRNSShare Option Restructuring
24th Oct 20228:31 amRNSDirectorate Change
21st Sep 20227:00 amRNS2022 Interim Results

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.